Lori A Wetmore

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy

Chad D. Touchberry, Troy M. Green, Vladimir Tchikrizov et al. · American Journal of Physiology-Endocrinology and Metabolism · 2013 · 195 citations

Life Sciences, Cardiology, Physiology +16

Antiproliferative effects of compounds derived from plants of Northeast Brazil

C. Pessoa, E. R. Silveira, Telma L. G. Lemos et al. · Phytotherapy Research · 2000 · 49 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to γ-radiation and BCNU

Adriana Brondani da Rocha, Dennis R.A. Mans, Elena Aida Bernard et al. · European Journal of Cancer · 1999 · 28 citations

Medicine, Cancer Biology, Oncology +14

Genotoxicity assessment of oxirane‐based dental monomers in mammalian cells

Elisabet L. Kostoryz, Lori A Wetmore, William G Brockmann et al. · Journal of Biomedical Materials Research Part A · 2004 · 20 citations

Pharmacy, Dental Materials Science, Toxicology +12

Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB

Chad D. Touchberry, Neerupma Silswal, Vladimir Tchikrizov et al. · BMC Pharmacology and Toxicology · 2014 · 16 citations · Full text

Life Sciences, Cardiology, Pharmacology +11